|
|
|
|
| LEADER |
01820nam a22003015i 4500 |
| 001 |
000283324 |
| 005 |
20211029091435.0 |
| 007 |
cr nn 008mamaa |
| 008 |
100301s2009 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9780387894454
|
| 024 |
7 |
|
|a 10.1007/978-0-387-89445-4
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Drug Resistance in Cancer Cells /
|c edited by Kapil Mehta, Zahid H. Siddik.
|
| 250 |
|
|
|a 1st ed. 2009.
|
| 260 |
# |
# |
|a New York, NY :
|b Springer New York :
|b Imprint: Springer,
|c 2009.
|
| 300 |
|
|
|a XVII, 363 p. 30 illus. :
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 505 |
0 |
|
|a Multidrug Resistance Mediated by MDR-ABC Transporters -- Metastasis and Drug Resistance -- The Role of Autophagy and Apoptosis in the Drug Resistance of Cancer -- Mechanisms of Resistance to Targeted Tyrosine Kinase Inhibitors -- Targeting Transglutaminase-2 to Overcome Chemoresistance in Cancer Cells -- Extracellular Matrix-Mediated Drug Resistance -- Oxidative Stress and Drug Resistance in Cancer -- Nuclear Factor-?B and Chemoresistance: How Intertwined Are They? -- Drug Resistance and the Tumor Suppressor p53: The Paradox of Wild-Type Genotype in Chemorefractory Cancers -- Resistance to Differentiation Therapy -- MicroRNAs and Drug Resistance -- Molecular Signatures of Drug Resistance -- Assessment of Drug Resistance in Anticancer Therapy by Nuclear Imaging -- Overcoming Drug Resistance by Phytochemicals.
|
| 650 |
|
0 |
|a Cancer research.
|
| 650 |
|
0 |
|a Pharmacology.
|
| 650 |
1 |
4 |
|a Cancer Research.
|
| 650 |
2 |
4 |
|a Pharmacology/Toxicology.
|
| 700 |
1 |
|
|a Mehta, Kapil.
|e editor.
|
| 700 |
1 |
|
|a Siddik, Zahid H.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|